Washington, D.C. – The Medical Imaging & Technology Alliance (MITA) – the leading trade association representing manufacturers of medical imaging equipment, radiopharmaceuticals, contrast media, and focused ultrasound therapeutic devices – applauded the passage of S.4348, The Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDASLA) by the Senate Health, Education, Labor and Pensions (HELP) Committee. Specifically, the bill includes provisions related to Food and Drug Administration (FDA) medical device user fees and advances user fee reauthorization.
“We appreciate...